在神经退行症中针对神经免疫机制的治疗向
Kathryn M Monroe1, Soyon Hong2, Joseph W Lewcock3
1Denali Therapeutics Inc., South San Francisco, CA, USA. monroe@dnli.com.
Nature reviews. Drug discovery
|February 16, 2026
概括
免疫系统,特别是中枢神经系统 (CNS) 中的微质,显著影响像阿尔茨海默氏症这样的神经退行性疾病. 了解这些神经免疫相互作用为药物发现提供了新的治疗目标和策略.
科学领域:
- 神经免疫学 神经免疫学
- 神经退行性疾病 神经退行性疾病
- 认知衰退的分子机制
背景情况:
- 对阿尔茨海默病和其他慢性神经退行性疾病的有效治疗是有限的,因为对认知衰退驱动因素的不完全理解.
- 人类遗传学和病理学研究强调了免疫系统在神经退行症进展中的重要作用.
- 研究主要集中在微质上,即中枢神经系统内存的先天性免疫细胞,进步了解它们的作用并确定治疗点.
研究的目的:
- 审查影响神经退行症的复杂的神经免疫相互作用.
- 探索中央和外周免疫系统如何影响疾病的结果.
- 确定神经退行性疾病的新型治疗策略和生物标志物.
主要方法:
- 审查关于神经炎症和神经退行现有的文献.
- 基因研究和疾病病理学的分析.
- 功能研究和微质细胞的转录概况的整合.
主要成果:
- 微细胞协调多样化的中枢神经系统和外围细胞群,以塑造神经退行性疾病的进展.
- 神经免疫相互作用揭示了免疫系统对神经退行影响的复杂框架.
- 现有知识表明,针对免疫路径的潜在新疗法策略.
结论:
- 了解神经免疫相互作用对于开发神经退行性疾病的有效治疗是至关重要的.
- 未来的药物发现应该考虑免疫标来补充现有疗法.
- 对于疾病特异性神经免疫生物标志物来指导治疗和诊断的需求至关重要.
相关概念视频
Alzheimer's Disease: Treatment
1.0K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.0K
Neurochemical Transmission: Sites of Drug Action
3.7K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
3.7K
Cytotoxic T Cells-mediated Immune Response
7.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
The Blood-brain Barrier
53.4K
Overview
53.4K


